Results 191 to 200 of about 2,761,482 (311)
Magnetic resonance: in vivo tissue characterization of the testes in patients with carcinoma‐in‐situ of the testis and healthy subjects [PDF]
C. Thomsen+5 more
openalex +1 more source
GATA3 is a sensitive marker for primary genital extramammary paget disease: An immunohistochemical study of 72 cases with comparison to gross cystic disease fluid protein 15 [PDF]
Cao, Dengfeng, et al,
core +2 more sources
X‐ray controlled release strategy in cancer therapy
A comprehensive review on the design principles and current strategies of X‐ray stimulated release systems in cancer therapy, focusing on the X‐ray responsive functional groups and materials as well as discussing the advantages and current challenges of X‐ray controlled release systems in cancer therapy.
Yiling Ruan+5 more
wiley +1 more source
Carcinoma in situ specimen classification based on intermediate cell measurements [PDF]
Michael W. Katzko+3 more
openalex +1 more source
In situ and early invasive bronchogenic carcinoma
Lewis B. Woolner+4 more
openalex +1 more source
Carcinoma in Situ of Contralateral Testis in Patients with Testicular Germ Cell Cancer: Study of 27 Cases in 500 Patients [PDF]
Hans von der Maase+8 more
openalex +1 more source
Abstract Background Hepatocellular carcinoma (HCC) is a deadly malignancy known for its ability to evade immune surveillance. NOP2/Sun RNA methyltransferase family member 2 (NSUN2), an RNA methyltransferase involved in carcinogenesis, has been associated with immune evasion and energy metabolism reprogramming.
Jinhua Jiang+6 more
wiley +1 more source
Abstract Background Radiotherapy (RT) is a key treatment modality in cancer therapy, utilizing high‐energy radiation to directly kill tumor cells. Recent research has increasingly highlighted RT's potential to indirectly enhance antitumor immunity. However, this immune activation alone often fails to generate sustained systemic antitumor responses.
Xuejiao Han+11 more
wiley +1 more source